Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure.
Zelinkova Z, van der Ent C, Bruin KF, van Baalen O, Vermeulen HG, Smalbraak HJ, Ouwendijk RJ, Hoek AC, van der Werf SD, Kuipers EJ, van der Woude CJ; Dutch Delta IBD Group. Zelinkova Z, et al. Among authors: van der woude cj, van baalen o, van der werf sd, van der ent c. Clin Gastroenterol Hepatol. 2013 Mar;11(3):318-21. doi: 10.1016/j.cgh.2012.10.024. Epub 2012 Oct 25. Clin Gastroenterol Hepatol. 2013. PMID: 23103819
Determinants of fatigue in Crohn's disease patients.
Vogelaar L, van't Spijker A, van Tilburg AJ, Kuipers EJ, Timman R, van der Woude CJ. Vogelaar L, et al. Among authors: van der woude cj, van t spijker a, van tilburg aj. Eur J Gastroenterol Hepatol. 2013 Feb;25(2):246-51. doi: 10.1097/MEG.0b013e32835aba83. Eur J Gastroenterol Hepatol. 2013. PMID: 23111414
Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).
Dewint P, Hansen BE, Verhey E, Oldenburg B, Hommes DW, Pierik M, Ponsioen CI, van Dullemen HM, Russel M, van Bodegraven AA, van der Woude CJ. Dewint P, et al. Among authors: van der woude cj, van bodegraven aa, van dullemen hm. Gut. 2014 Feb;63(2):292-9. doi: 10.1136/gutjnl-2013-304488. Epub 2013 Mar 23. Gut. 2014. PMID: 23525574 Clinical Trial.
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Ferrante M, Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens GR, van der Woude CJ, Danese S, Diamond RH, Oortwijn AF, Tang KL, Miller M, Cornillie F, Rutgeerts PJ; International Organization for the Study of Inflammatory Bowel Diseases. Ferrante M, et al. Among authors: van der woude cj. Gastroenterology. 2013 Nov;145(5):978-986.e5. doi: 10.1053/j.gastro.2013.08.010. Epub 2013 Aug 14. Gastroenterology. 2013. PMID: 23954314 Clinical Trial.
Disappointing durable remission rates in complex Crohn's disease fistula.
Molendijk I, Nuij VJ, van der Meulen-de Jong AE, van der Woude CJ. Molendijk I, et al. Among authors: van der woude cj, van der meulen de jong ae. Inflamm Bowel Dis. 2014 Nov;20(11):2022-8. doi: 10.1097/MIB.0000000000000148. Inflamm Bowel Dis. 2014. PMID: 25159455 Clinical Trial.
Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Undergoing Regular Colonoscopic Surveillance.
Mooiweer E, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, van Bodegraven AA, Jansen JM, Mahmmod N, Kremer W, Siersema PD, Oldenburg B; Dutch Initiative on Crohn’s and Colitis. Mooiweer E, et al. Among authors: van der woude cj, van bodegraven aa, van der meulen de jong ae. Clin Gastroenterol Hepatol. 2015 Sep;13(9):1656-61. doi: 10.1016/j.cgh.2015.04.183. Epub 2015 May 6. Clin Gastroenterol Hepatol. 2015. PMID: 25956835
278 results